USDA plans exclusive ASF vaccine license to Huvepharma

USDA plans exclusive ASF vaccine license to Huvepharma

Agency posts notice to grant exclusive license for experimental ASF vaccine

Array

According to a notice on the Federal Register, the license is to be granted to Huvepharma for Patent No. 9,463,234, “ATTENUATED AFRICAN SWINE FEVER VIRUS STRAIN INDUCES PROTECTION AGAINST CHALLENGE WITH HOMOLOGOUS VIRULENT PARENTAL VIRUS GEORGIA 2007 ISOLATE”, issued on October 11, 2016.